Soaring Demand Set to Propel Diuretics Market to $0.88 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Diuretics Market Through 2025?
Recent years have seen a consistent growth in the diuretics market size. It is projected to surge from $0.74 billion in 2024 to $0.77 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 3.4%. The expansion during the historic period is a consequence of factors such as the rise in chronic diseases, an aging population, clinical guidelines, innovation in the pharmaceutical sector, and a surge in obesity.

What's the Projected Size of the Global Diuretics Market by 2029?
The market size of diuretics is predicted to witness a consistent surge in the upcoming years. It is anticipated to expand to "$0.88 billion by 2029, flourishing at a compound annual growth rate (CAGR) of 3.5%. Factors contributing to the growth in the forecast timeframe comprise escalating occurrences of hypertension and heart failure, emerging markets, government initiatives, and an emphasis on preventive healthcare. Foreseen trends within the forecast span involve personalized medicine, innovative pharmaceutical development, telehealth plus remote surveillance, and digital health solutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/diuretics-drugs-global-market-report

Top Growth Drivers in the Diuretics Industry: What's Accelerating the Market?
An escalation in the prevalence of renal and kidney diseases propels the diuretics market forward. The malfunctioning of kidneys in these cases necessitates the use of water pills (diuretic drugs) to ensure regular urine flow. Altered lifestyles, characterized by consumption of a diet excessive in calcium and other minerals, contribute to the increase in kidney disorders. As an illustration, the Centers for Disease Control and Prevention (CDC), a public health agency based in the U.S., estimated in May 2024 that about 14% of U.S. adults, or nearly 35.5 million people, are possibly living with chronic kidney diseases. Consequently, the surge in renal and kidney disorder cases boosts the expansion of the diuretics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2439&type=smp

What Are the Key Trends Driving Diuretics Market Growth?
Major firms active in the diuretics market are prioritizing the development of advanced products, such as prescription medicines, to improve treatment effectiveness and decrease side effects for individuals diagnosed with conditions like heart failure and hypertension. Prescription drugs are medicines that require a doctor's prescription, hence ensuring their rightful use for their intended medical cases under professional guidance. Glenmark Pharmaceuticals Limited, a pharmaceutical company based in India, for example, in January 2023, rolled out a generic product of the diuretic Bumetanide Injection designed for managing fluid retention and swelling in conditions like congestive heart failure. The product comes in two variants, 1 mg/4 mL single-dose vials and 2.5 mg/10 mL multi-dose vials, both having a concentration of 0.25 mg/mL. This injectable is utilized to treat edema (fluid build-up) triggered by conditions such as congestive heart failure, liver disease, and kidney disease effectively, leading to an increase in urine production which helps ease symptoms like swelling and breathing difficulties.

What Are the Main Segments in the Diuretics Market?
The diuretics market covered in this report is segmented -

1) By Type: Osmotic Diuretics, Carbonic Anhydrase Inhibitors, Loop Diuretics, Thiazides And Thiazide-Like Diuretics, Aldosterone Antagonists
2) By Distribution: Hospital Pharmacies, Independent Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies
3) By Application: Hypertension, Glaucoma, Heart Failure, Kidney Stones

Subsegments:
1) By Osmotic Diuretics: Mannitol, Glycerin, Urea
2) By Carbonic Anhydrase Inhibitors: Acetazolamide, Dorzolamide, Brinzolamide
3) By Loop Diuretics: Furosemide, Bumetanide, Torsemide, Ethacrynic Acid
4) By Thiazides And Thiazide-Like Diuretics: Hydrochlorothiazide, Chlorthalidone, Indapamide, Metolazone
5) By Aldosterone Antagonists: Spironolactone, Eplerenone

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2439&type=smp

Which Top Companies are Driving Growth in the Diuretics Market?
Major companies operating in the diuretics market include Merck & Co. Inc., Meda Manufacturing GmbH, Pfizer Inc., GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Aton Pharma Inc., Boehringer Ingelheim International GmbH, Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi-aventis U.S. LLC, Centaur Pharmaceuticals Pvt Ltd, Validus Pharmaceuticals LLC, Actavis Generics, Paddock Laboratories LLC, Perrigo Pharmaceutical Company, H. Lundbeck Inc., Oak Pharmaceuticals Inc., Akron Pharmaceuticals Inc., Salix Pharmaceuticals Inc., Alembic Pharmaceuticals Limited, Aurobindo Pharma Limited, IPCA Laboratories Limited, Jubilant Cadista Pharmaceuticals Limited, Mylan N.V., Princeton Laboratories Inc., Sciegen Pharma Limited, Unichem Laboratories Limited, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Cipla Ltd, F Hoffmann-La Roche Ltd, Fresenius Kabi AG, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd, Zydus Lifesciences Ltd., Amneal Pharmaceuticals LLC, Apotex Inc.

Which Regions Will Dominate the Diuretics Market Through 2029?
North America was the largest region in the diuretics market in 2024. The Middle East is expected to be the fastest-growing region in the diuretics market during the forecast period. The regions covered in the diuretics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2439

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.